miR-122-5p Inhibits the Proliferation, Invasion and Growth of Bile Duct Carcinoma Cells by Targeting ALDOA

• Published in: Cellular physiology and biochemistry Vol. 48; no. 6; pp. 2596 - 2606
• Main Authors: Xu, Zhuo, Liu, Guangchao, Zhang, Meng, Zhang, Zhilei, Jia, Yuming, Peng, Li, Zhu, Yanhong, Hu, Jianbin, Huang, Runying, Sun, Xiaonan
• Format: Journal Article
• Language: English
• Published: Basel, Switzerland S. Karger AG 01.08.2018; Cell Physiol Biochem Press GmbH & Co KG
• Subjects: 3' Untranslated Regions; ALDOA; Animals; Antagomirs - metabolism; Antagomirs - therapeutic use; Apoptosis; Bile; Bile duct carcinoma; Bile Duct Neoplasms - drug therapy; Bile Duct Neoplasms - metabolism; Bile Duct Neoplasms - pathology; Bile ducts; Biomarkers; Cancer therapies; Cell growth; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chemotherapy; Fructose-Bisphosphate Aldolase - antagonists & inhibitors; Fructose-Bisphosphate Aldolase - genetics; Fructose-Bisphosphate Aldolase - metabolism; Hospitals; Humans; Invasion; Liver cancer; Male; Medical prognosis; Membranes; Metastasis; Mice; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; MicroRNAs - antagonists & inhibitors; MicroRNAs - genetics; MicroRNAs - metabolism; miR-122-5p; Original Paper; Proliferation; RNA Interference; RNA, Small Interfering - metabolism; Up-Regulation; Grand Island; United States > US; China; miR-122-5p; Proliferation; ALDOA; Bile duct carcinoma; Invasion
• ISSN: 1015-8987; 1421-9778
• DOI: 10.1159/000492702

Background/Aims: Bile duct cancer, although not among the most common tumors, still accounts for more and more worldwide deaths each year. By attempting to verify an overexpression of ALDOA in cholangiocarcinoma tissues and cells and explore the underlying molecular mechanism regulated by miR-122-5p, this study was designed to provide a potential molecular target in bile duct cancer treatment. Methods: Western blot and immunohistochemistry were performed to detect the ALDOA protein level in duct carcinoma tissues. The transfection efficiency was confirmed by western blot and/or RT-qPCR assay. The proliferation of bile duct carcinoma cells was determined by MTT and colony formation assay. The invasion ability of bile duct carcinoma cells was evaluated with Transwell invasion assay. Flow cytometry detected cell apoptosis of bile duct carcinoma cells. The miRNAs which modulate ALDOA were filtrated from bioinformatics software and clinical specimens. The target relationship was confirmed by dual luciferase reporter assay. Furthermore, a xenograft model was completed to verify the impact of miRNA on inhibition growth of bile duct carcinoma cells. Results: ALDOA was found up-regulated in bile duct carcinoma tissues and cells. Knockdown of ALDOA promoted the apoptosis of cells and inhibited the proliferation and invasion of bile duct carcinoma cells. Bioinformatics and clinical specimens indicated the negative correlation and targeted regulation between miR-122-5p and ALDOA. By down-regulating ALDOA, overexpression of miR-122-5p appeared to promote cell apoptosis and significantly inhibit cell proliferation, invasion in vitro and suppress the tumor growth in vivo. Conclusion: miR-122-5p inhibited proliferation and invasion of bile duct carcinoma cells and promoted cell apoptosis by targeting ALDOA expression.